Brief: Granules Says FDA Inspection At Unit Concludes With Five Observations
Dec 19 (Reuters) - Granules India Ltd GRAN.NS: GRANULES LIFE SCIENCES COMPLETES FDA INSPECTION INSPECTION CONCLUDES WITH FIVE PROCEDURAL OBSERVATIONS NONE OF THE OBSERVATIONS ARE ASSOCIATED WITH DATA INTEGRITY OR PRODUCT SAFETY Source text: ID:nNSE2nmjCr Further company coverage: GRAN.NS ((Reutersbriefs@thomsonreuters.com;))
Recent news on Granules India
See all newsGranules India profit surges as higher sales outweigh cost pressures
Brief: Granules India Q2 Consol Profit 1.82 Billion Rupees
Brief: Granules Says Incorporated Wholly Owned Subsidiary Triton Farmaceutica S.A. De C.V. In Mexico
Brief: Granules Promoter Group Pays 10.93 Billion Rupees For Preferential Issue
Granules India falls after key shareholder trims stake